Omitting Aspirin in High-Risk Left Ventricular Assist Device Implant.
作者信息
Reza Nosheen
机构信息
Division of Cardiovascular Medicine, Department of Medicine, Penn Medicine, Perelman School of Medicine at the University of Pennsylvania, Philadelphia.
出版信息
JAMA Cardiol. 2025 Mar 1;10(3):243-244. doi: 10.1001/jamacardio.2024.4861.
Abstract
摘要
相似文献
1
Omitting Aspirin in High-Risk Left Ventricular Assist Device Implant.高危左心室辅助装置植入术中省略阿司匹林治疗
JAMA Cardiol. 2025 Mar 1;10(3):243-244. doi: 10.1001/jamacardio.2024.4861.
2
Low thromboembolic risk for patients with the Heartmate II left ventricular assist device.使用Heartmate II左心室辅助装置的患者血栓栓塞风险较低。
J Thorac Cardiovasc Surg. 2008 Nov;136(5):1318-23. doi: 10.1016/j.jtcvs.2007.12.077. Epub 2008 Sep 14.
3
Influence of implant strategy on the transition from temporary left ventricular assist device to durable mechanical circulatory support.植入策略对临时左心室辅助装置向持久机械循环支持过渡的影响。
Eur J Cardiothorac Surg. 2024 Oct 1;66(4). doi: 10.1093/ejcts/ezae333.
4
Management of Ischemic Stroke Following Left Ventricular Assist Device.左心室辅助装置后缺血性脑卒中的处理。
J Stroke Cerebrovasc Dis. 2020 Dec;29(12):105384. doi: 10.1016/j.jstrokecerebrovasdis.2020.105384. Epub 2020 Oct 24.
5
HeartWare left ventricular assist device thrombosis in aspirin non-responder.
Asian Cardiovasc Thorac Ann. 2014 Feb;22(2):203-4. doi: 10.1177/0218492312467993. Epub 2013 Jul 11.
6
The impact of uncorrected mild aortic insufficiency at the time of left ventricular assist device implantation.左心室辅助装置植入时未纠正的轻度主动脉瓣关闭不全的影响。
J Thorac Cardiovasc Surg. 2020 Dec;160(6):1490-1500.e3. doi: 10.1016/j.jtcvs.2020.02.144. Epub 2020 May 7.
7
When Ablation Is Not the Answer: Acute Left Main Thrombosis Causing Incessant Ventricular Tachycardia Following Left Ventricular Assist Device Implant.当消融并非解决方案时：左心室辅助装置植入后急性左主干血栓形成导致持续性室性心动过速
Cureus. 2017 Oct 21;9(10):e1790. doi: 10.7759/cureus.1790.
8
A novel, highly discriminatory risk model predicting acute severe right ventricular failure in patients undergoing continuous-flow left ventricular assist device implant.一种新型的、高度区分性的风险模型，可预测接受左心室辅助装置持续血流植入术的患者发生急性严重右心室衰竭的风险。
Artif Organs. 2019 Jul;43(7):624-632. doi: 10.1111/aor.13413. Epub 2019 Jan 25.
9
Longitudinal change in quality of life and impact on survival after left ventricular assist device implantation.左心室辅助装置植入术后生活质量的纵向变化及其对生存的影响。
Ann Thorac Surg. 2004 Apr;77(4):1321-7. doi: 10.1016/j.athoracsur.2003.09.089.
10
Bleeding in patients with continuous-flow left ventricular assist devices: acquired von Willebrand disease or antithrombotics?左心室辅助装置持续血流患者的出血：获得性血管性血友病还是抗血栓药物？
Eur J Cardiothorac Surg. 2022 Jun 15;62(1). doi: 10.1093/ejcts/ezab474.
本文引用的文献
1
Aspirin and Hemocompatibility After LVAD Implantation in Patients With Atherosclerotic Vascular Disease: A Secondary Analysis From the ARIES-HM3 Randomized Clinical Trial.阿司匹林与动脉粥样硬化性血管疾病患者左心室辅助装置植入后的血液相容性：来自ARIES-HM3随机临床试验的二次分析
JAMA Cardiol. 2025 Mar 1;10(3):235-242. doi: 10.1001/jamacardio.2024.4849.
2
The Society of Thoracic Surgeons Intermacs 2024 Annual Report: Focus on Outcomes in Younger Patients.胸外科医师协会Intermacs 2024年度报告：关注年轻患者的治疗结果
Ann Thorac Surg. 2025 Jan;119(1):34-58. doi: 10.1016/j.athoracsur.2024.10.003. Epub 2024 Oct 21.
3
An ISHLT consensus statement on strategies to prevent and manage hemocompatibility related adverse events in patients with a durable, continuous-flow ventricular assist device.国际心脏和肺移植学会（ISHLT）关于预防和管理使用持久性连续血流心室辅助装置患者血液相容性相关不良事件策略的共识声明。
J Heart Lung Transplant. 2024 Aug;43(8):1199-1234. doi: 10.1016/j.healun.2024.04.065. Epub 2024 Jun 14.
4
Evaluation of the Hemocompatibility of the Direct Oral Anticoagulant Apixaban in Left Ventricular Assist Devices: The DOAC LVAD Study.评估直接口服抗凝药阿哌沙班在左心室辅助装置中的血液相容性：DOAC-LVAD 研究。
JACC Heart Fail. 2024 Sep;12(9):1540-1549. doi: 10.1016/j.jchf.2024.04.013. Epub 2024 May 7.
5
A Prospective Randomized Trial of Direct Oral Anticoagulant Therapy With a Fully Magnetically Levitated LVAD: The DOT-HM3 Study.一项使用完全磁悬浮左心室辅助装置进行直接口服抗凝治疗的前瞻性随机试验：DOT-HM3研究。
Circulation. 2024 Aug 6;150(6):509-511. doi: 10.1161/CIRCULATIONAHA.124.069726. Epub 2024 Apr 9.
6
Aspirin and Hemocompatibility Events With a Left Ventricular Assist Device in Advanced Heart Failure: The ARIES-HM3 Randomized Clinical Trial.阿司匹林与左心室辅助装置在晚期心力衰竭中的血液相容性事件：ARIES-HM3 随机临床试验。
JAMA. 2023 Dec 12;330(22):2171-2181. doi: 10.1001/jama.2023.23204.
Zotero 插件